HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 227 filers reported holding HORIZON PHARMA PLC in Q3 2015. The put-call ratio across all filers is 0.46 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $881,000 | +16.7% | 53,200 | 0.0% | 0.00% | – |
| Q1 2018 | $755,000 | -2.8% | 53,200 | 0.0% | 0.00% | – |
| Q4 2017 | $777,000 | +15.1% | 53,200 | 0.0% | 0.00% | – |
| Q3 2017 | $675,000 | -96.6% | 53,200 | -96.8% | 0.00% | -100.0% |
| Q2 2017 | $19,882,000 | +0.3% | 1,674,990 | +24.9% | 0.01% | 0.0% |
| Q1 2017 | $19,824,000 | -6.5% | 1,341,290 | +2.3% | 0.01% | -9.1% |
| Q4 2016 | $21,211,000 | -20.6% | 1,310,990 | -11.1% | 0.01% | -21.4% |
| Q3 2016 | $26,726,000 | +5.5% | 1,474,100 | -4.2% | 0.01% | 0.0% |
| Q2 2016 | $25,340,000 | +19.8% | 1,538,570 | +20.5% | 0.01% | +27.3% |
| Q1 2016 | $21,155,000 | +3952.7% | 1,276,730 | +5195.9% | 0.01% | – |
| Q4 2015 | $522,000 | -97.2% | 24,108 | -97.5% | 0.00% | -100.0% |
| Q3 2015 | $18,756,000 | – | 946,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,609,894 | $109,460,000 | 3.84% |
| Avoro Capital Advisors LLC | 5,593,683 | $92,631,000 | 3.57% |
| Broadfin Capital, LLC | 1,339,575 | $22,183,000 | 3.49% |
| SCOPIA CAPITAL MANAGEMENT LP | 11,912,290 | $197,268,000 | 3.45% |
| JW Asset Management, LLC | 270,775 | $4,484,000 | 2.86% |
| Rhenman & Partners Asset Management AB | 1,632,212 | $27,029,000 | 2.77% |
| Paulson & Co. | 7,670,700 | $127,027,000 | 2.60% |
| Redwood Investments, LLC | 1,315,149 | $21,779,000 | 1.50% |
| KOPP INVESTMENT ADVISORS LLC | 93,220 | $1,544,000 | 1.45% |
| 1492 Capital Management LLC | 72,951 | $1,208,000 | 0.86% |